HCA Healthcare (HCA) Expected to Announce Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA) is anticipated to announce its earnings results before the market opens on Friday, April 25th. Analysts expect the company to announce earnings of $5.77 per share and revenue of $18.26 billion for the quarter. HCA Healthcare has set its FY 2025 guidance at 24.050-25.850 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the business posted $5.90 earnings per share. On average, analysts expect HCA Healthcare to post $25 EPS for the current fiscal year and $28 EPS for the next fiscal year.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $334.38 on Friday. The stock has a market capitalization of $82.32 billion, a PE ratio of 15.22, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare has a 12 month low of $289.98 and a 12 month high of $417.14. The business has a 50 day simple moving average of $328.34 and a 200-day simple moving average of $335.10.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

An institutional investor recently bought a new position in HCA Healthcare stock. Brighton Jones LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,402 shares of the company’s stock, valued at approximately $1,021,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Truist Financial lowered their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada decreased their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Robert W. Baird reaffirmed a “neutral” rating and set a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday. Finally, Guggenheim began coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a “neutral” rating for the company. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $381.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.